This page contains brief information about obinutuzumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
|US Brand Name(s):||Gazyva|
Obinutuzumab is approved to be used with chlorambucil to treat:
- Chronic lymphocytic leukemia (CLL). It is used in patients who have not already been treated for CLL.
Obinutuzumab is also being studied in the treatment of other types of cancer.More About Obinutuzumab
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.Research Results
Combination of Obinutuzumab Plus Chlorambucil Improves Survival in Patients With Chronic Lymphocytic Leukemia and Other Health Conditions - Important clinical trial results for this drug, background information, and how the trial was done.Clinical Trials Accepting Patients
Find Clinical Trials for Obinutuzumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.